Docosahexaenoic Acid (DHA) Supplementation in Amblyopia

NCT03402789 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Hopkins failed to review contract with company providing complimentary dha, support was withdrawn necessitating me to get more grant money to fund study which was unsucccessful.

Conditions

Interventions

Sponsor

Johns Hopkins University